PDA for Kidneys Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-7
SponsorUniversity of Wisconsin, Madison
About this trial
The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury.
Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.
Eligibility criteria
Qualifiers
Delivered at <32 weeks' gestation
≤72 hours of age
Inpatient at Meriter Hospital, Inc. NICU
At least one parent/guardian is able to provide parental permission in English or Spanish
Disqualifiers
Major congenital anomalies of kidney
Attending physician's discretion to not place NIRS sensors due to clinical concerns
In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life
Birth parent aged <18
Trial design
Treatments tested in this trial
- Near Infrared Spectroscopy
Treatment groups
45 Participants
are divided into 1 treatment groupLocations
1Meriter Hospital, Inc.53715, MadisonWisconsin, United States
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
The Gerber Foundation
Collaborator
Source ClinicalTrials.gov